反応と合成の進歩シンポジウム 発表要旨概要
第37回反応と合成の進歩シンポジウム
セッションID: 1P-02
会議情報

11:20~12:40 ポスターショートプレゼンテーション, 13:20~14:25 ポスター発表
対称分岐型オリゴグリセロールによる医薬品の薬効改善
*根本 尚夫服部 初彦宮本 理人土屋 浩一郎
著者情報
会議録・要旨集 フリー

詳細
抄録

We have developed symmetrically branched oligoglycerols (BGL) such as dimer (BGL002) and trimer (BGL003) as G2, hexamer (BGL006) and heptamers (BGL007) as G3, and dodecamer (BGL012) and tetradecamer (BGL014) as G4 dendrons. BGL family possess 2n (n = 1—3) of primary hydroxides at terminal region for water-solubilizing and⁄or water-affinity, and OH, NH, NH2, or N3 group and further linkered structures at apex region for the covalent bond formation of various molecules (BGLation) such as poorly water-soluble medicines or molecules with poorly water-affinity. We report chemistry of BGLations and the property of the resulting BGLated derivatives such as fibrates, paclitaxel, p-borophenylalanine, piceatannnol, artificial protein drug and liposome.

Fullsize Image
著者関連情報
© 2011 日本薬学会
前の記事 次の記事
feedback
Top